May 12, 2022 / 11:30AM GMT
Operator
Hello, everyone, and welcome to the Pharming's First Quarter Results Conference Call. My name is Victoria, and I'll be coordinating your call today. (Operator Instructions)
I'll now pass over to your host, Dr. Sijmen de Vries, CEO, to begin. Please go ahead.
Sijmen de Vries - Pharming Group N.V. - President, CEO & Executive Director
Thank you very much, Victoria. Good afternoon, and good morning, ladies and gentlemen. Welcome to our first quarter results call today.
And before I go into that, I would like to go to Slide #2 and point you to the slide that shows forward-looking statements as we will be making some forward-looking statements that are based upon our current beliefs, expectations and assumptions and, of course, as you all know, things may change towards the future.
So having said that, I would like to move to Slide #3. I'm here together with my 2 colleagues, Jeroen Wakkerman, our Chief Financial Officer; and Anurag Relan, our Chief Medical Officer, who will take you to the respective parts of this presentation.
Q1 2022 Pharming Group NV Earnings Call Transcript
May 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers